Immunotherapies are promising blood cancer treatments, but they do not work for every patient. To develop optimized therapeutics, researchers use sophisticated single cell techniques to understand patients’ responses to existing therapies and discover new drug targets by tracking gene expression and profiling the immune response in heterogenous cell populations.
Download this article from 10x Genomics to discover how single cell analyses enable drug discovery and development in hematological oncology.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.